(Q24240501)

English

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

scientific article (publication date: 7 October 2009)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

Europe PubMed Central

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Robert J Norman

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Thomas Tang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jonathan M Lord

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ephia Yasmin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Adam H Balen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

7 October 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Cochrane Database of Systematic Reviews

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

CD003053

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

21 January 2018

Maternal morbid obesity and the risk of adverse pregnancy outcome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

21 January 2018

Screening women with polycystic ovary syndrome for metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

21 January 2018

Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

21 January 2018

The impact of obesity on reproduction in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

21 January 2018

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating the equivalence of clomiphene citrate with and without metformin in ovulation induction in PCOS patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Does metformin induce ovulation in normoandrogenic anovulatory women?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome in young Korean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Negative lifestyle is associated with a significant reduction in fecundity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 2 diabetes and polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

What role of estrogens in ovarian stimulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone-induced liver failure: a case study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovary syndrome: current and future treatment paradigms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis of polycystic ovary syndrome--the enigma unravels?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity and weight loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of lifestyle modification in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Finnish Diabetes Prevention Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is metformin the treatment of choice for anovulation in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovaries and associated clinical and biochemical features in young women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathophysiology of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovary syndrome and fat distribution: the central issue?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is insulin resistance an essential component of PCOS?: The influence of confounding factors.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus on infertility treatment related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity and reproductive disorders in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasound assessment of the polycystic ovary: international consensus definitions.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving reproductive performance in overweight/obese women with effective weight management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fat and female fecundity: prospective study of effect of body fat distribution on conception rates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of obesity: need to focus on high risk abdominally obese patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of metformin on hirsutism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003053.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD003053.PUB3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

release_c2fu67nj7jcqheu7sozazx2nbq

1 reference

https://api.fatcat.wiki/v0/release/c2fu67nj7jcqheu7sozazx2nbq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821299%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24240501&oldid=1836824894"